1. Short title This Act may be cited as the Younger Onset Alzheimer’s Disease Act . 2. Findings Congress finds the following: (1) Approximately 5,800,000 individuals in the United States are living with Alzheimer’s disease. This includes approximately 200,000 individuals with younger onset Alzheimer’s disease. (2) Alzheimer’s disease costs the United States more than $290,000,000 per year, including $195,000,000 in costs to Medicare and Medicaid. (3) The Older Americans Act of 1965 ( 42 U.S.C. 3001 et seq.) includes services that focus on the needs of individuals with Alzheimer’s disease and related disorders. The need to specifically support individuals with younger onset Alzheimer’s disease is growing. 3. Younger onset Alzheimer’s disease The Older Americans Act of 1965 is amended— (1) in section 302(3) ( 42 U.S.C. 3022(3) ), by striking an individual with Alzheimer's disease and inserting an individual of any age with Alzheimer's disease ; and (2) in section 711(6) ( 42 U.S.C. 3058f(6) ), by inserting of any age after individual . 4. Report (a) In general Not later than 300 days after the date of enactment of this Act, and annually thereafter, the Assistant Secretary for Aging shall submit a report, to the committees of Congress described in subsection (b), that includes— (1) an overview of programmatic functions and performance with respect to the amendments made by section 3, including information about individuals with younger onset Alzheimer’s disease; and (2) an identification of the gaps in needs of individuals with younger onset Alzheimer’s disease. (b) Committees The committees of Congress described in this subsection are— (1) the Special Committee on Aging, the Committee on Health, Education, Labor, and Pensions, and the Committee on Finance, of the Senate